Physician profile
Michael Y Oh
NPI 1275508525
$74,968.19
in general payments reported to CMS, 2019-2025
35 companies · $61K in 2025
The $61K reported for 2025 was more than what 96% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $1,834 · 2020: $259 · 2021: $522 · 2022: $4,638 · 2023: $2,472 · 2024: $4,689 · 2025: $61K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $51K · Food and Beverage: $8,217 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $6,750 · Travel and Lodging: $1,823.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $50,925.00 |
| Food and Beverage | $8,217.10 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $6,750.00 |
| Travel and Lodging | $1,822.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gs Solutions, INC. | $39,647.54 | 2019-2025 | |
| Xtant Medical INC | $9,443.57 | 2025 | |
| Spineology INC. | $9,373.85 | 2022-2025 | Optimesh Expandable Interbody Fusion System |
| Kyocera Medical Technologies, INC. | $4,448.37 | 2023-2025 | |
| Medtronic, INC. | $3,340.79 | 2021-2025 | Mazor X System, Aquamantys(Tm), Anteralign Spinal System With Titan Nanolock Surface Technology |
| Mml US, INC. | $1,282.44 | 2022-2025 | Reactiv8 |
| Globus Medical, INC. | $1,255.24 | 2022-2025 | Hedron Ia, Senza, Mars |
| Stryker Corporation | $1,223.71 | 2019-2025 | N/A, 1788, Mild Device Kit |
| Si-Bone, INC. | $895.95 | 2019-2023 | |
| Abbott Laboratories | $748.20 | 2019-2025 | Axium, Proclaim |
| Nuvasive, INC. | $428.83 | 2021-2023 | Alif |
| Integrity Implants INC. Dba Accelus | $323.10 | 2023-2024 | |
| Biotronik Nro, INC. | $317.97 | 2023-2024 | Biotronik, Prospera |
| Centinel Spine, LLC | $281.18 | 2024-2025 | Prodisc L |
| Augmedics INC. | $258.05 | 2024 | Xvision |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $178.72 | 2024-2025 | 7d Surgical System |
| Integrity Implants INC. | $137.62 | 2022 | |
| Neo Spine USA, INC. | $132.40 | 2024-2025 | Neo Pedicle Screw System |
| Alphatec Spine, INC | $131.71 | 2021 | |
| Medtronic USA, INC. | $128.67 | 2019-2020 | |
| Baxter Healthcare | $123.92 | 2022-2023 | Actifuse |
| Depuy Synthes Sales INC. | $106.71 | 2025 | Velys |
| Kuros Biosciences USA, INC | $99.43 | 2025 | Magnetos |
| Surgalign Spine Technologies, INC. | $94.75 | 2022 | |
| Boston Scientific Corporation | $91.96 | 2024-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Surgical Theater. INC. | $89.70 | 2025 | |
| Cerapedics INC. | $83.33 | 2021 | |
| Amplify Surgical, INC. | $79.67 | 2023 | Dualx and Dualportal |
| Icotec Medical INC. | $62.60 | 2023 | Icotec Blackarmor Spine System |
| Spineart USA INC | $56.78 | 2023 | Perla Tl |
| Life Spine, INC. | $55.67 | 2022 | |
| Carlsmed, INC. | $45.76 | 2022 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$16,891.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Oh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.